Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nafamostat vs Heparinized Saline Priming in CRRT for AKI
NCT01486485Phase 3Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2012
- Primary completion
- Aug 2013
- Countries
- 1
01
Overview
A Phase 3 trial of Nafabelltan in acute kidney injury (AKI), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
Nafabelltan
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01486485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486485.